30 Nov -0001
Rockville, Md. The global urodynamic devices market is set to reach US$ 265 Mn by 2022, according to Fact.MR, on the back of new device technologies, wider testing networks and better reimbursement for urological tests. Advances such as intravesical prostatic protrusion measurement, condom catheters, ultrasound video urodynamics and penile cuffs are broadening what these devices can do.
North America is the largest region, uroflowmetry leads the product mix, and hospitals account for most testing. Awareness campaigns are drawing more patients in, easing the social stigma around urological conditions.
Uroflowmetry devices hold more than a fourth of revenue, widely used to diagnose prostate cancer, benign prostatic hypertrophy, urinary blockage, bladder cancer and bladder dysfunction, while urodynamic catheters grow fastest through 2022. By setting, hospitals lead and near US$ 150 Mn by 2022, with North America the largest contributor, while urology clinics are the fastest-growing end user.
North America stays dominant on rising disease prevalence and quick adoption across healthcare centres, while Asia Pacific excluding Japan grows fastest on rising incidence, higher incomes and unmet patient needs.
The market runs on detection and awareness. With the World Health Organization estimating over 300,000 new bladder cancer patients a year and roughly 200 million people affected by urinary incontinence, campaigns such as the UK's Continence Awareness Week and Japan's continence initiatives are encouraging more people to seek diagnosis, lifting demand through the forecast period.
The field brings together urology device specialists.
For device makers, growth favours advanced uroflowmetry and catheter products. Investors get a small, specialised market with a firm clinical tailwind. Procurement and hospital teams can plan around hospitals leading demand, uroflowmetry carrying volume, and North America offering the largest opportunity while Asia Pacific grows fastest through 2022.
Fact.MR's study covers the global urodynamic devices market for the 2017 to 2022 forecast period, with segmentation by product type, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the urodynamic devices market report.
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.
Urodynamic Devices Market
Free SampleAbout Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. We are known for our syndicated research, custom research, and consulting solutions.